Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenic Obesity and Associated Risk Factors in Patients Undergone Liver Transplant

Authors not listed

University of Bari · 2021

Abstract

The prevalence of obesity in cirrhotic patients who are candidates for liver transplantation (LT) is increasing, a phenomenon consistent with the increased prevalence of obesity in the general population. On the other hand, in liver patients on the waiting list for transplantation it is often observed sarcopenia. The combination of the two condition is defined sarcopenic obesity, which combines the negative synergy deriving from the two conditions. In this study the investigators will evaluate, for the first time, the prevalence of sarcopenic obesity in subjects undergone LT and determine the possible associated risk factors, particularly the role of immunosuppressive treatment with calcineurin inhibitors in addition to dietary habits and physical activity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Anonymous. (2021). Sarcopenic Obesity and Associated Risk Factors in Patients Undergone Liver Transplant. <em>University of Bari</em>. https://clinicaltrials.gov/study/NCT05029713
Vancouver
Anonymous. Sarcopenic Obesity and Associated Risk Factors in Patients Undergone Liver Transplant. University of Bari. 2021.
BibTeX
@misc{anon2021Sarcop, title = {Sarcopenic Obesity and Associated Risk Factors in Patients Undergone Liver Transplant}, author = {Anonymous}, journal = {University of Bari}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings